159
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 12 April 2018 EMA/204541/2018 Rev 1 Human Medicines Evaluation Division Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for methotrexate containing medicinal products Referral under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data Procedure number: EMEA/H/A-31/1463 Jylamvo EMEA/H/A-31/1463/C/3756/0002 Nordimet EMEA/H/A-31/1463/C/3983/0006

Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

  • Upload
    lamkien

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom

An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

12 April 2018 EMA/204541/2018 Rev 1 Human Medicines Evaluation Division

Annex I

List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for methotrexate containing medicinal products

Referral under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data

Procedure number: EMEA/H/A-31/1463

Jylamvo EMEA/H/A-31/1463/C/3756/0002

Nordimet EMEA/H/A-31/1463/C/3983/0006

Page 2: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 2/159

Nationally authorised medicinal products

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Accord Healthcare Limited Methofill Methotrexate 0.15ml/7.5mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.25ml/12.5mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.2ml/10mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.35ml/17.5mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.3ml/15mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.45ml/22.5mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.4ml/20mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.55ml/27.5mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.5ml/25mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Austria Accord Healthcare Limited Methofill Methotrexate 0.6ml/30mg

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 3: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 3/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Austria Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection Subcutaneous Use

Page 4: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 4/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection Subcutaneous Use

Austria Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection Subcutaneous Use

Austria Ebewe Pharma Ebetrexat Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Austria Ebewe Pharma Ebetrexat Methotrexate 10mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Austria Ebewe Pharma Ebetrexat Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 5: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 5/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Ebewe Pharma Ebetrexat Methotrexate Disodium 10.97mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Austria Ebewe Pharma Ebetrexat Methotrexate 10mg Tablet

Tablet Oral Use

Austria Ebewe Pharma Ebetrexat Methotrexate 2.5mg Tablet

Tablet Oral Use

Austria Ebewe Pharma Ebetrexat Methotrexate 5mg Tablet

Tablet Oral Use

Austria Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 6: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 6/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Austria Pfizer Corporation Austria Gesellschaft M.B.H.

Methotrexat "lederle"

Methotrexate Disodium 27.41mg Vial

Solution For Injection/Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Page 7: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 7/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Austria Pfizer Corporation Austria Gesellschaft M.B.H.

Methotrexat "lederle"

Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Belgium Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 8: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 8/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Belgium Aurobindo Pharma B.V. Methotrexaat Ab Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 9: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 9/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 10: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 10/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Belgium Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 5.48mg

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Belgium Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 8.23mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Page 11: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 11/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Belgium Pfizer S.A. (Belgium) Ledertrexate Concentrate

Methotrexate Disodium 1096.8mg

Concentrate For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Belgium Pfizer S.A. (Belgium) Ledertrexate Concentrate

Methotrexate Disodium 5483.7mg

Concentrate For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Belgium Sandoz N.V. Ebetrexat Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Sandoz N.V. Ebetrexat Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Belgium Sandoz N.V. Methotrexate Sandoz

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intravenous Use

Belgium Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 5000mg/50ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 12: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 12/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Belgium Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Belgium Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 5mg/2ml Solution For Injection Intraarticular Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 13: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 13/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Bulgaria Accord Healthcare Limited Инжексат Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Инжексат Accord Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Bulgaria Accord Healthcare Limited Метотрексат Акорд

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Bulgaria Accord Healthcare Limited Метотрексат Акорд

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Bulgaria Accord Healthcare Limited Метотрексат Акорд

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Bulgaria Actavis Group Ptc Ehf. Намаксир Methotrexate 10mg/0.4ml

Solution For Injection Intravenous Use

Bulgaria Actavis Group Ptc Ehf. Намаксир Methotrexate 15mg/0.38ml

Solution For Injection Intravenous Use

Bulgaria Actavis Group Ptc Ehf. Намаксир Methotrexate 2.5mg/0.33ml

Solution For Injection Intravenous Use

Bulgaria Actavis Group Ptc Ehf. Намаксир Methotrexate 7.5mg/0.3ml

Solution For Injection Intravenous Use

Bulgaria Ebewe Pharma Ebetrexat Methotrexate 10mg/Ml Solution For Injection Intravenous Use

Bulgaria Ebewe Pharma Ebetrexat Methotrexate 20mg/Ml Solution For Injection Intravenous Use

Bulgaria Ebewe Pharma Метотрексат Ебеве

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Page 14: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 14/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Bulgaria Ebewe Pharma Метотрексат Ебеве

Methotrexate 10mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Bulgaria Ebewe Pharma Метотрексат Ебеве

Methotrexate 10mg Tablet

Tablet Oral Use

Bulgaria Ebewe Pharma Метотрексат Ебеве

Methotrexate 2.5mg Tablet

Tablet Oral Use

Bulgaria Ebewe Pharma Метотрексат Ебеве

Methotrexate 5mg Tablet

Tablet Oral Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Meтожект Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 15: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 15/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Bulgaria Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Метожект Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 16: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 16/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Croatia Cipla Europe Nv Metotreksat Cipla Methotrexate 10mg Tablet

Tablet Oral Use

Croatia Cipla Europe Nv Metotreksat Cipla Methotrexate 2.5mg Tablet

Tablet Oral Use

Croatia Medis Adria D.O.O. Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 17: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 17/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Croatia Pliva Hrvatska D.O.O. Metotreksat Pliva Methotrexate 50mg/2ml

Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Croatia Pliva Hrvatska D.O.O. Metotreksat Pliva Methotrexate 1000mg/10ml

Solution For Injection/Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Croatia Pliva Hrvatska D.O.O. Metotreksat Pliva Methotrexate 2.5mg/Ml Solution For Injection/Infusion

Intramuscular Use | Intravenous Use

Croatia Sandoz D.O.O. Ebetrexat Methotrexate 20mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Croatia Sandoz D.O.O. Metotreksat Sandoz

Methotrexate Disodium 2.5mg Tablet

Tablet Oral Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 18: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 18/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Cyprus Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In A Pre-Filled Syringe.

Intramuscular Use | Intravenous Use | Subcutaneous Use

Cyprus Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Cyprus Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 19: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 19/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Cyprus Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Cyprus Accord Healthcare Limited Methotrexate Accord

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Cyprus Pfizer Hellas, A.E. Methotrexate Pfizer Methotrexate 2.5mg Tablet

Tablet Oral Use

Cyprus Pharmaceutical Trading Co Ltd

Methotrexate Pharmaceutical Trading Co

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Cyprus Remedica Ltd Methotrexate Remedica

Methotrexate 2.5mg Tablet

Film-Coated Tablet Oral Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 20: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 20/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Czech Republic Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Page 21: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 21/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Czech Republic Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate Disodium 10.97mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg Tablet

Tablet Oral Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate 2.5mg Tablet

Tablet Oral Use

Czech Republic Ebewe Pharma Methotrexat Ebewe Methotrexate 5mg Tablet

Tablet Oral Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 22: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 22/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 23: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 23/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Czech Republic Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Czech Republic Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Czech Republic Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Czech Republic Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Czech Republic Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Denmark Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 24: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 24/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Denmark Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Denmark Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Page 25: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 25/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Denmark Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection Intravenous Use

Denmark Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection Intravenous Use

Denmark Cipla Europe Nv Methotrexate Cipla Methotrexate 2.5mg Tablet

Tablet Oral Use

Denmark Ebewe Pharma Ebetrex Methotrexate Disodium 21.94mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Denmark Ebewe Pharma Methotrexat ”ebewe”

Methotrexate 10mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Denmark Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Denmark Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg Tablet

Tablet Oral Use

Denmark Ebewe Pharma Methotrexat Ebewe Methotrexate 2.5mg Tablet

Tablet Oral Use

Denmark Ebewe Pharma Methotrexat Ebewe Methotrexate 5mg Tablet

Tablet Oral Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 26: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 26/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 27: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 27/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Denmark Orion Corporation Methotrexate "orion"

Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Denmark Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Denmark Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Denmark Pfizer Aps Methotrexate "pfizer"

Methotrexate 25mg/Ml Solution For Injection/Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Denmark Pharmachemie B.V Emthexate Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intravenous Use

Denmark Pharmachemie B.V Emthexate Methotrexate 2.5mg Tablet

Tablet Oral Use

Denmark Sandoz A/S Methotrexat Sandoz

Methotrexate 2.5mg Tablet

Tablet Oral Use

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Page 28: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 28/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/40ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/20ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Ebewe Pharma Ebetrex Methotrexate 10.97mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Estonia Ebewe Pharma Ebetrex Methotrexate 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Estonia Ebewe Pharma Methotrexate Ebewe

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 29: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 29/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 30: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 30/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Estonia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Estonia Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Estonia Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Estonia Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Finland Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Page 31: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 31/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Finland Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Finland Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Finland Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Finland Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Finland Accord Healthcare Limited Methotrexat Accord Methotrexate 10mg Tablet

Tablet Oral Use

Finland Accord Healthcare Limited Methotrexat Accord Methotrexate 2.5mg Tablet

Tablet Oral Use

Finland Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Finland Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 32: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 32/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Finland Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Finland Ebewe Pharma Ebetrex Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Finland Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 33: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 33/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.04ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Finland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 34: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 34/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Finland Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Finland Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Finland Orion Corporation Trexan Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Finland Orion Oyj Trexan Methotrexate 2.5mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Finland Orion Oyj Trexan Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Finland Orion Oyj Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Finland Orion Oyj Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Finland Pfizer Oy Methotrexate Pfizer Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Finland Pfizer Oy Methotrexate Pfizer Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 35: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 35/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 36: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 36/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Accord Healthcare France Sas Methotrexate Accord

Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

France Laboratoire Biodim Ledertrexate Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

France Laboratoire Biodim Methotrexate Biodim

Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intradiscal Use | Intramuscular Use | Intravenous Use | Subcutaneous Use

France Laboratoire Biodim Methotrexate Biodim

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Page 37: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 37/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 38: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 38/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

France Mylan S.A.S Méthotrexate Mylan

Methotrexate 100mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

France Mylan S.A.S Méthotrexate Mylan

Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

France Mylan S.A.S Méthotrexate Mylan

Methotrexate 50mg/2ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

France Mylan S.A.S Méthotrexate Mylan

Methotrexate 2.5mg/Ml Solution For Injection Intravenous Use

France Nordic Group B.V. Imeth Methotrexate 10mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 12.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Page 39: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 39/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Nordic Group B.V. Imeth Methotrexate 12.5mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 15mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 15mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 17.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 17.5mg/0.7ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 20mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 20mg/0.8ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 22.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 22.5mg/0.9ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 25mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Page 40: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 40/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

France Nordic Group B.V. Imeth Methotrexate 7.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Group B.V. Imeth Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

France Nordic Pharma Imeth Methotrexate 10mg Tablet

Tablet Oral Use

France Nordic Pharma Imeth Methotrexate 2.5mg Tablet

Tablet Oral Use

France Pfizer Holding France Novatrex Methotrexate 2.5mg Tablet

Tablet Oral Use

France Sanofi-Aventis France Methotrexate Bellon

Methotrexate 2.5mg Tablet

Tablet Oral Use

France Teva Santé Methotrexate Teva Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use | Subcutaneous Use

France Teva Santé Methotrexate Teva Methotrexate 5g/20ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use | Subcutaneous Use

France Teva Santé Methotrexate Teva Methotrexate 1000mg/10ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

France Teva Santé Methotrexate Teva Methotrexate 50mg/2ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 41: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 41/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Germany Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 42: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 42/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Germany Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Germany Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Germany Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 43: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 43/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Addenda Pharma S.R.L. Aldesta Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Aliud Pharma Gmbh Methotrexat Al Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 44: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 44/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Astron Research Limited Methotrexate Astron

Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Astron Research Limited Methotrexate Astron

Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Bendalis Gmbh Bendatrexat Methotrexate 50mg/2ml

Solution For Injection Parenteral Use

Germany Hexal Ag Methotrexat Hexal Methotrexate 25mg/Ml Solution For Injection/Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Hexal Ag Mtx Methotrexate Disodium 10.96mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Germany Hexal Ag Mtx Methotrexate Disodium 16.44mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Page 45: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 45/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Hexal Ag Mtx Methotrexate Disodium 5.48mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Germany Hexal Ag Mtx Methotrexate Disodium 8.22mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use | Subcutaneous Use

Germany Hexal Ag Mtx Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Hexal Ag Mtx Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Hexal Ag Mtx Methotrexate Disodium 10.96mg Tablet

Tablet Oral Use

Germany Hexal Ag Mtx Methotrexate Disodium 16.44mg Tablet

Tablet Oral Use

Germany Hexal Ag Mtx Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Germany Hexal Ag Mtx Methotrexate Disodium 5.48mg Tablet

Tablet Oral Use

Germany Hexal Ag Mtx Methotrexate Disodium 8.22mg Tablet

Tablet Oral Use

Germany Hexal Ag Neotrexat Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 46: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 46/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate Disodium 8.22mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Oral Use | Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate Disodium 10.96mg Tablet

Tablet Oral Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate Disodium 8.22mg Tablet

Tablet Oral Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 47: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 47/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 48: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 48/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Methotrexat Medac Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Methotrexat Medac Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Methotrexat Medac Methotrexate Disodium 16.44mg/3ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Trexject Methotrexate 10mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 49: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 49/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mundipharma Gmbh Methotrexat Mundipharma

Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Germany Mylan Dura Gmbh Mtx Methotrexate 7.5mg/Ml Solution For Injection Intramuscular Use | Intravenous Injection | Subcutaneous Use

Germany Orion Corporation Mtx Orion Methotrexate 10mg Tablet

Tablet Oral Use

Germany Orion Corporation Mtx Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Methotrexate Disodium 10.96mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Methotrexate Disodium 8.22mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Fs Methotrexate Disodium 10.96mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 50: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 50/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Pfizer Pharma Pfe Gmbh Lantarel Fs Methotrexate Disodium 16.44mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Fs Methotrexate Disodium 21.92mg/0.8ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Fs Methotrexate Disodium 27.41mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Pfizer Pharma Pfe Gmbh Lantarel Fs Methotrexate Disodium 8.22mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat “lederle“

Methotrexate Disodium 10.96mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat “lederle“

Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat Lösung "lederle"

Methotrexate Disodium 1096mg Vial

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat Lösung "lederle"

Methotrexate Disodium 548.37mg Vial

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat Lösung "lederle"

Methotrexate Disodium 5483mg Vial

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat Lösung "lederle"

Methotrexate Disodium 27.41mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Pfizer Pharma Pfe Gmbh Methotrexat Lösung "lederle"

Methotrexate Disodium 54.83mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Page 51: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 51/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Germany Rosemont Pharmaceuticals Limited

Methotrexat Rosemont

Methotrexate Disodium 2.19mg/Ml

Oral Solution Oral Use

Germany Stada Arzneimittel Ag Methotrexat Stada Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Subcutaneous Use

Germany Stadapharm Gmbh Methotrexat Stada Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Subcutaneous Use

Germany Teva Gmbh Methotrexat Gry Methotrexate Disodium 54.84mg/2ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Teva Gmbh Methotrexate Gry Methotrexate Disodium 1096.73mg/10ml

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Teva Gmbh Methotrexate Gry Methotrexate Disodium 548.37mg/20ml

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Teva Gmbh Methotrexate Gry Methotrexate Disodium 5483.7mg/50ml

Concentrate For Solution For Infusion

Intramuscular Use | Intrathecal Use | Intravenous Use

Germany Teva Gmbh Methotrexate Gry Methotrexate Disodium 5.48mg/2ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 52: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 52/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Greece Chemipharm S.G. De Tchaves & Cie E.E

Emthexate Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Chemipharm S.G. De Tchaves & Cie E.E

Emthexate Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 53: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 53/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Greece Chemipharm S.G. De Tchaves & Cie E.E

Emthexate Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Chemipharm S.G. De Tchaves & Cie E.E

Emthexate Methotrexate 5mg/2ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Chemipharm S.G. De Tchaves & Cie E.E

Emthexate Methotrexate 2.5mg Tablet

Tablet Oral Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 54: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 54/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Greece Medicus A.E Methobion Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Medicus A.E Methobion Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 55: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 55/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Greece Medicus A.E Methobion Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Pfizer Hellas, A.E. Methotrexate Pfizer Methotrexate 1000mg/40ml

Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Greece Pfizer Hellas, A.E. Methotrexate Pfizer Methotrexate 2.5mg Tablet

Tablet Oral Use

Hungary Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 22mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Page 56: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 56/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Hungary Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Hungary Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Page 57: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 57/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Page 58: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 58/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Hungary Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Hungary Ebewe Pharma Ebetrexat Methotrexate Disodium 20mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Hungary Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 59: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 59/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 60: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 60/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Hungary Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Hungary Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Hungary Orion Corporation Methotrexate Orion Methotrexate 25mg Tablet

Tablet Oral Use

Hungary Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Hungary Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Hungary Sandoz Hungária Kft Ebetrexat Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Hungary Sandoz Hungária Kft Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Hungary Sandoz Hungária Kft Methotrexat Ebewe Methotrexate 10mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 61: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 61/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Iceland Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 62: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 62/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 63: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 63/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Iceland Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Iceland Pfizer Aps Methotrexate Pfizer Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Iceland Pfizer Aps Methotrexate Pfizer Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Iceland Pfizer Aps Methotrexate Pfizer Methotrexate 2.5mg Tablet

Tablet Oral Use

Ireland Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Page 64: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 64/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Ireland Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Page 65: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 65/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Ireland Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Injector

Subcutaneous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 66: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 66/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 10mg Tablet

Tablet Oral Use

Ireland Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 2.5mg Tablet

Tablet Oral Use

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 10mg Tablet

Tablet Oral Use

Page 67: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 67/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Ireland Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 2.5mg Tablet

Tablet Oral Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Ireland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Ireland Mercury Pharmaceuticals Ltd. Methotrexate Mercury Pharmaceuticals

Methotrexate 2.5mg Tablet

Tablet Oral Use

Page 68: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 68/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Ireland Morningside Healthcare Ltd Methotrexate Morningside Healthcare

Methotrexate 10mg Tablet

Tablet Oral Use

Ireland Morningside Healthcare Ltd Methotrexate Morningside Healthcare

Methotrexate 2.5mg Tablet

Tablet Oral Use

Ireland Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Ireland Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Ireland Rosemont Pharmaceuticals Limited

Methotrexate Rosemont Pharmaceuticals

Methotrexate Disodium 2.19mg/Ml

Oral Solution Oral Use

Italy Accord Healthcare Limited Metother Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 69: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 69/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Accord Healthcare Limited Metother Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metother Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Page 70: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 70/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Accord Healthcare Limited Metotrexato Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Italy Accord Healthcare Limited Metotrexato Accord Healthcare Limited

Methotrexate 2.5mg Tablet

Tablet Oral Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 71: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 71/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Addenda Pharma S.R.L. Metotrexato Addenda

Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Alfasigma S.P.A. Reumaflex Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Injection

Page 72: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 72/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Difa Cooper S.P.A. Velos Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Difa Cooper S.P.A. Velos Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 73: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 73/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Doc Generici S.R.L. Metotrexato Doc Generici

Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 74: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 74/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Mundipharma Pharmaceuticals Srl

Immutrex Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 75: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 75/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 5.484mg Vial

Powder For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intratumoral Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 10.968mg/1.33ml

Solution For Injection In Pre-Filled Syringe

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intratumoral Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 16.452mg/2ml

Solution For Injection In Pre-Filled Syringe

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intratumoral Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 21.936mg/2.66ml

Solution For Injection In Pre-Filled Syringe

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intratumoral Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 8.226mg/Ml

Solution For Injection In Pre-Filled Syringe

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intratumoral Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 1.097g Vial

Powder For Solution For Injection

Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 54.84mg Vial

Powder For Solution For Injection

Intramuscular Use | Intravenous Use

Page 76: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 76/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 548.4mg Vial

Powder For Solution For Injection

Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 1.097g/10ml

Solution For Injection Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 5.484g/50ml

Solution For Injection Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 54.84mg/2ml

Solution For Injection Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 548.4mg/20ml

Solution For Injection Intramuscular Use | Intravenous Use

Italy Pfizer Italia S.R.L. Methotrexate Pfizer Italia

Methotrexate Sodium 2.742mg Tablet

Tablet Oral Use

Italy Pfizer Italia S.R.L. Metotrexato Pfizer Methotrexate 100mg Vial

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Pfizer Italia S.R.L. Metotrexato Pfizer Methotrexate 1g Bottle Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Pfizer Italia S.R.L. Metotrexato Pfizer Methotrexate 500mg Bottle

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Pfizer Italia S.R.L. Metotrexato Pfizer Methotrexate 50mg Vial Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 77: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 77/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy Pfizer Italia S.R.L. Metotrexato Pfizer Methotrexate 5mg Vial Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy S.F. Group Srl Afslamet Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Italy S.F. Group Srl Afslamet Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy S.F. Group Srl Afslamet Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 78: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 78/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Italy S.F. Group Srl Afslamet Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Italy Teva Italia S.R.L. Metotressato Teva Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Italy Teva Italia S.R.L. Metotressato Teva Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Latvia Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Latvia Accord Healthcare Limited Methotrexate Accord

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Latvia Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Latvia Ebewe Pharma Ebetrex Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Latvia Ebewe Pharma Methotrexate Ebewe

Methotrexate 2.5mg Tablet

Tablet Oral Use

Latvia Ebewe Pharma Methotrexate Ebewe

Methotrexate 5mg Tablet

Tablet Oral Use

Page 79: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 79/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 80: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 80/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Latvia Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Latvia Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Latvia Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Latvia Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 81: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 81/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Lithuania Accord Healthcare Limited Methotrexate Accord

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Page 82: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 82/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Lithuania Accord Healthcare Limited Metother Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 83: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 83/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Lithuania Accord Healthcare Limited Metother Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Accord Healthcare Limited Metother Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Lithuania Ebewe Pharma Ebetrexat Methotrexate Disodium 20mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Lithuania Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Lithuania Ebewe Pharma Methotrexat Ebewe Methotrexate 2.5mg Tablet

Tablet Oral Use

Lithuania Ebewe Pharma Methotrexat Ebewe Methotrexate 5mg Tablet

Tablet Oral Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 1.25mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 84: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 84/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 17.5mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 85: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 85/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Lithuania Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Lithuania Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Lithuania Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Lithuania Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Luxembourg Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 5.48mg

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Luxembourg Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 8.23mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Luxembourg Pfizer S.A. (Belgium) Ledertrexate Methotrexate Disodium 2.74mg Tablet

Tablet Oral Use

Page 86: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 86/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Luxembourg Pfizer S.A. (Belgium) Ledertrexate Concentrate

Methotrexate Disodium 1096.8mg

Concentrate For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Luxembourg Pfizer S.A. (Belgium) Ledertrexate Concentrate

Methotrexate Disodium 5483.7mg

Concentrate For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

Luxembourg Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 25mg/Ml Injection Epidural Use | Intrabursal Use | Intracoronary Use | Intradiscal Use | Intramuscular Use | Intravenous Use | Perineural Use | Retrobulbar Use

Luxembourg Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intracoronary Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Luxembourg Teva Pharma Belgium N.V./S.A

Emthexate Methotrexate 5000mg/50ml

Solution For Injection Intraarterial Use | Intracoronary Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 87: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 87/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 10mg Tablet

Tablet Oral Use

Malta Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 2.5mg Tablet

Tablet Oral Use

Malta Actavis Group Ptc Ehf. Methotrexate Actavis

Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 1g/10ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Page 88: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 88/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 1g/40ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 250mg/10ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Malta Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 5g/50ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 89: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 89/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Netherlands Accord Healthcare Limited Methotrexaat Accord

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 90: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 90/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Addenda Pharma S.R.L. Aldesta Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Netherlands Aurobindo Pharma B.V. Methotrexaat Aurobindo

Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 91: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 91/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Centrafarm B.V. Methotrexaat Cf Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 92: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 92/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 93: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 93/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Netherlands Mylan B.V. Methotrexaat Mylan

Methotrexate 100mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Injection

Netherlands Mylan B.V. Methotrexaat Mylan

Methotrexate 2.5mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Injection

Netherlands Mylan B.V. Methotrexaat Mylan

Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Injection

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 10mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Page 94: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 94/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 12.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 15mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 17.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 20mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 22.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 25mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Nordic Group B.V. Methotrexaat Nordic

Methotrexate 7.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Pharmachemie B.V Emthexate Pf Methotrexate 100mg Vial

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Pharmachemie B.V Emthexate Pf Methotrexate 25mg Vial Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Pharmachemie B.V Emthexate Pf Methotrexate 5mg Vial Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Pharmachemie B.V Methotrexaat Pch Methotrexate 10mg Tablet

Tablet Oral Use

Page 95: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 95/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Pharmachemie B.V Methotrexaat Pch Methotrexate 2.5mg Tablet

Tablet Oral Use

Netherlands Sandoz B.V. Ebetrex Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Sandoz B.V. Ebetrex Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Sandoz B.V. Methotrexaat Sandoz

Methotrexate 10mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Netherlands Sandoz B.V. Methotrexaat Sandoz

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intravenous Use

Netherlands Sandoz B.V. Methotrexaat Sandoz

Methotrexate Disodium 10mg Tablet

Tablet Oral Use

Netherlands Sandoz B.V. Methotrexaat Sandoz

Methotrexate Disodium 2.5mg Tablet

Tablet Oral Use

Netherlands Sandoz B.V. Methotrexaat Sandoz

Methotrexate Disodium 7.5mg Tablet

Tablet Oral Use

Netherlands Sandoz B.V. Methotrexaat Sandoz B.V.

Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Sandoz B.V. Methotrexaat Sandoz B.V.

Methotrexate 25mg/Ml Solution For Injection Intravenous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Pen

Intramuscular Use | Subcutaneous Use

Page 96: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 96/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Pen

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 10mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 12.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 15mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 17.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 20mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 22.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 25mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 7.5mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 12.5mg/0.5ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 15mg/0.6ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Page 97: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 97/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 17.5mg/0.7ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 20mg/0.8ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 22.5mg/0.9ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Netherlands Teva Nederland B.V. Methotrexaat Teva Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Pen

Intravenous Use | Subcutaneous Use

Netherlands Teva Pharma B.V. Methotrexate Teva Methotrexate 100mg/Ml Powder For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Teva Pharma B.V. Methotrexate Teva Methotrexate 2.5mg/Ml Powder For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Netherlands Teva Pharma B.V. Methotrexate Teva Methotrexate 25mg/Ml Powder For Solution For Injection

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 98: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 98/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Norway Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 99: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 99/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Accord Healthcare Limited Methotrexate Accord

Methotrexate 2.5mg Tablet

Tablet Oral Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 10mg/0.4ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 12.5mg/0.31ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 15mg/0.38ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 17.5mg/0.44ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 2.5mg/0.33ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 20mg/0.5ml

Solution For Injection Intravenous Use

Page 100: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 100/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 22.5mg/0.56ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 25mg/0.63ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 27.5mg/0.69ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 30mg/0.75ml

Solution For Injection Intravenous Use

Norway Actavis Group Ptc Ehf. Remianza Methotrexate 7.5mg/0.3ml

Solution For Injection Intravenous Use

Norway Cipla Europe Nv Methotrexate Cipla Methotrexate 2.5mg Tablet

Tablet Oral Use

Norway Ebewe Pharma Ebetrex Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Norway Ebewe Pharma Ebetrex Methotrexate 100ml/Ml Concentrate For Solution For Infusion

Intravenous Use

Norway Ebewe Pharma Ebetrex Methotrexate 2.5mg Tablet

Tablet Oral Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 101: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 101/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 102: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 102/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Norway Orion Corporation Methotrexate Orion Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Norway Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Norway Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Norway Pfizer As Methotrexate Pfizer Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Norway Pfizer As Methotrexate Pfizer Methotrexate 2.5mg Tablet

Tablet Oral Use

Norway Teva Sweden Ab Methotrexate Teva Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intravenous Use

Norway Teva Sweden Ab Methotrexate Teva Methotrexate 2.5mg Tablet

Tablet Oral Use

Poland Accord Healthcare Limited Methofill Methotrexate 10mg Tablet

Tablet Oral Use

Page 103: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 103/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Accord Healthcare Limited Methofill Methotrexate 2.5mg Tablet

Tablet Oral Use

Poland Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 104: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 104/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 105: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 105/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Poland Accord Healthcare Limited Metotreksat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 106: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 106/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Poland Ebewe Pharma Ebetrexat Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Poland Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Poland Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Poland Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg Tablet

Tablet Oral Use

Poland Ebewe Pharma Methotrexat Ebewe Methotrexate 2.5mg Tablet

Tablet Oral Use

Page 107: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 107/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Ebewe Pharma Methotrexat Ebewe Methotrexate 5mg Tablet

Tablet Oral Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 108: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 108/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 10mg Tablet

Tablet Oral Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 2.5mg Tablet

Tablet Oral Use

Poland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 7.5mg Tablet

Tablet Oral Use

Poland Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Page 109: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 109/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Poland Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Poland Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Poland Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Accord Healthcare Limited Metotrexato Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 110: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 110/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 12.5mg/0.3125ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 22.5mg/0.5625ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Addenda Pharma S.R.L. Aldesta Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 100mg/4ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 111: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 111/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 1g/10ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Laboratórios Pfizer, Lda. Fauldexato Methotrexate 5g/50ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Portugal Laboratórios Pfizer, Lda. Ledertrexato Methotrexate 2.5mg Tablet

Tablet Oral Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 112: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 112/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Portugal Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metex Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 113: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 113/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Portugal Teva Pharma – Produtos Farmacêuticos Lda

Methotrexate Teva Methotrexate 26mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Teva Pharma – Produtos Farmacêuticos Lda

Methotrexato Teva Methotrexate 104mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Teva Pharma – Produtos Farmacêuticos Lda

Metotrexato Teva Methotrexate 1040mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Teva Pharma – Produtos Farmacêuticos Lda

Metotrexato Teva Methotrexate 52mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Portugal Teva Pharma – Produtos Farmacêuticos Lda

Metotrexato Teva Methotrexate 26ml/Ml Solution For Injection Intramuscular Use

Romania Accord Healthcare Limited Methofill Methotrexate 10mg Tablet

Tablet Oral Use

Romania Accord Healthcare Limited Methofill Methotrexate 2.5mg Tablet

Tablet Oral Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Page 114: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 114/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Romania Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Romania Ebewe Pharma Methotrexat Ebewe Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania Ebewe Pharma Methotrexat Ebewe Methotrexate Disodium 21.94mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 115: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 115/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Romania Ebewe Pharma Methotrexat Ebewe Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania Ebewe Pharma Metotrexate Ebewe Methotrexate 10mg/Ml Solution For Injection Intravenous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 116: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 116/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Romania S.C. Rompharm Company S.R.L.

Metorthrit Methotrexate 10mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania S.C. Rompharm Company S.R.L.

Metorthrit Methotrexate 15mg/1.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania S.C. Rompharm Company S.R.L.

Metorthrit Methotrexate 20mg/2ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Romania S.C. Rompharm Company S.R.L.

Metorthrit Methotrexate 7.5mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 117: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 117/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovakia Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovakia Accord Healthcare Limited Methotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Slovakia Accord Healthcare Limited Methotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 118: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 118/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovakia Accord Healthcare Limited Methotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Slovakia Accord Healthcare Limited Metotrexát Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Slovakia Accord Healthcare Limited Metotrexát Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Slovakia Accord Healthcare Limited Metotrexát Accord Methotrexate 50mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Slovakia Ebewe Pharma Methotrexat Ebewe Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Slovakia Ebewe Pharma Methotrexat Ebewe Methotrexate 10mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovakia Ebewe Pharma Methotrexat Ebewe Methotrexate 20mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovakia Ebewe Pharma Methotrexat Ebewe Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 119: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 119/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 120: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 120/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovakia Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

Slovakia Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Slovakia Orion Corporation Trexan Methotrexate 10mg Tablet

Tablet Oral Use

Slovakia Orion Corporation Trexan Methotrexate 2.5mg Tablet

Tablet Oral Use

Slovakia Sandoz Pharmaceuticals D.D. Methotrexat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Slovakia Teva Pharmaceuticals Slovakia S.R.O

Methotrexate Teva Methotrexate Sodium 10mg Tablet

Tablet Oral Use

Slovakia Teva Pharmaceuticals Slovakia S.R.O

Methotrexate Teva Methotrexate Sodium 2.5mg Tablet

Tablet Oral Use

Slovenia Actavis Group Ptc Ehf. Metotreksat Actavis

Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 121: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 121/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Slovenia Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 122: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 122/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate Disodium 10mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate 20mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intravenous Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate 10mg Tablet

Tablet Oral Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate 2.5mg Tablet

Tablet Oral Use

Slovenia Ebewe Pharma Metotreksat Ebewe Methotrexate 5mg Tablet

Tablet Oral Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/30ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 123: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 123/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 124: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 124/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Slovenia Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 125: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 125/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Accord Healthcare S.L.U. Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 126: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 126/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Accord Healthcare S.L.U. Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Spain Accord Healthcare S.L.U. Metotrexato Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 127: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 127/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Addenda Pharma S.R.L. Aldesta Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Spain Cipla Europe Nv Metotrexato Cipla Methotrexate 2.5mg Tablet

Tablet Oral Use

Page 128: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 128/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Ebewe Pharma Bertanel Methotrexate 10mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 12.5mg/0.625ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 15mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 17.5mg/0.875ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 20mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 22.5mg/1.125ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 25mg/1.25ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 27.5mg/1.375ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 30mg/1.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate Disodium 21.94mg/Ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Ebewe Pharma Bertanel Methotrexate 10mg/Ml Solution For Injection Intravenous Use

Page 129: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 129/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Ebewe Pharma Metotrexato Ebewe Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Spain Especialidades Farmaceuticas Centrum, S.A

Quinux Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Especialidades Farmaceuticas Centrum, S.A

Quinux Methotrexate 15mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Especialidades Farmaceuticas Centrum, S.A

Quinux Methotrexate 20mg/0.8ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Especialidades Farmaceuticas Centrum, S.A

Quinux Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Especialidades Farmaceuticas Centrum, S.A

Quinux Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Laboratorio Stada, S.L. Glofer Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 130: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 130/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 131: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 131/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 132: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 132/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Spain Mylan Pharmaceuticals S.L. Metotrexato Mylan Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Nordic Group B.V. Imeth Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 12.5mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 15mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 17.5mg/0.7ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 20mg Syringe

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 22.5mg/0.9ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Spain Nordic Group B.V. Imeth Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Page 133: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 133/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Spain Pfizer, S.L. Metotrexato Pfizer Methotrexate 25mg/Ml Solution For Injection Intramuscular Use | Intravenous Use

Spain Wyeth Farma, S.A Metotrexato Wyeth Methotrexate Sodium 1g/40ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Wyeth Farma, S.A Metotrexato Wyeth Methotrexate Sodium 500mg/20ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Wyeth Farma, S.A Metotrexato Wyeth Methotrexate Sodium 5g/200ml

Solution For Injection Intramuscular Use | Intrathecal Use | Intravenous Use

Spain Wyeth Farma, S.A Metotrexato Wyeth Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Accord Healthcare Limited Injexate Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 134: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 134/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Accord Healthcare Limited Injexate Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Injexate Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 135: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 135/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Accord Healthcare Limited Metotrexat Accord Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Page 136: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 136/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 12.5mg/0.3125ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 15mg/0.375ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 27.5mg/0.6875ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 137: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 137/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Addenda Pharma S.R.L. Methotrexate Addenda

Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Astron Research Limited Metotrexat Astron Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 138: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 138/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Cipla Europe Nv Methotrexate Cipla Methotrexate 10mg Tablet

Tablet Oral Use

Sweden Cipla Europe Nv Methotrexate Cipla Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Difa Cooper S.P.A. Velos Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Solution For Injection

Sweden Difa Cooper S.P.A. Velos Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 139: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 139/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Difa Cooper S.P.A. Velos Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Difa Cooper S.P.A. Velos Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Ebewe Pharma Ebetrex Methotrexate Disodium 21.94mg/Ml

Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Sweden Ebewe Pharma Ebetrex Methotrexate 10mg Tablet

Tablet Oral Use

Sweden Ebewe Pharma Ebetrex Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Ebewe Pharma Ebetrex Methotrexate 5mg Tablet

Tablet Oral Use

Sweden Ebewe Pharma Methotrexate Ebewe

Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 140: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 140/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 141: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 141/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metojectpen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 142: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 142/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metopen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 143: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 143/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 10mg Tablet

Tablet Oral Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotab Methotrexate 7.5mg Tablet

Tablet Oral Use

Sweden Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metotrexat Medac Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

Sweden Orion Corporation Methotrexate Orion Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Sweden Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Orion Corporation Methotrexate Orion Pharma

Methotrexate 10mg Tablet

Tablet Oral Use

Sweden Orion Corporation Methotrexate Orion Pharma

Methotrexate 2.5mg Tablet

Tablet Oral Use

Sweden Pfizer Ab Methotrexate Pfizer Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 144: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 144/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Pfizer Ab Methotrexate Pfizer Methotrexate 25mg/Ml Solution For Injection/Infusion

Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Sweden Sigillata Limited Husmetabo Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Sigillata Limited Husmetabo Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 145: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 145/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

Sweden Sigillata Limited Husmetabo Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Sweden Teva Sweden Ab Methotrexate Teva Methotrexate 100mg/Ml Concentrate For Solution For Infusion

Intraarterial Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

Page 146: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 146/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Intravenous Use | Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Accord Healthcare Limited Methofill Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 147: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 147/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Accord Healthcare Limited Methotrexate Accord

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/40ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 1000mg/10ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 5000mg/50ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Accord Healthcare Limited Methotrexate Accord Healthcare

Methotrexate 500mg/5ml

Concentrate For Solution For Infusion

Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 12.5mg/0.31ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 15mg/0.38ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 17.5mg/0.44ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

Page 148: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 148/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 2.5mg/0.33ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 20mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 22.5mg/0.56ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 25mg/0.63ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 27.5mg/0.69ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 30mg/0.75ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Actavis Group Ptc Ehf. Namaxir Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Subcutaneous Use

United Kingdom Cipla (Eu) Limited Methotrexate Cipla (Eu)

Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Cipla (Eu) Limited Methotrexate Cipla (Eu)

Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Ebewe Pharma Ebetrex Methotrexate 10mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

United Kingdom Ebewe Pharma Ebetrex Methotrexate 20mg/Ml Solution For Injection Intramuscular Use | Intravenous Use | Subcutaneous Use

Page 149: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 149/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Ebewe Pharma Methotrexate Ebewe Pharma

Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Ebewe Pharma Methotrexate Ebewe Pharma

Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Ebewe Pharma Methotrexate Ebewe Pharma

Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Hameln Pharmaceuticals Ltd Methotrexate Hameln Pharmaceuticals

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

United Kingdom Hameln Pharmaceuticals Ltd Methotrexate Hameln Pharmaceuticals

Methotrexate 5mg/2ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use | Intraventricular Use

United Kingdom Hameln Pharmaceuticals Ltd Methotrexate Hameln Pharmaceuticals

Methotrexate 5000mg/50ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Hameln Pharmaceuticals Ltd Methotrexate Hameln Pharmaceuticals

Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 1g/40ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

Page 150: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 150/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 2.5mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 250mg/10ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 500mg/20ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 50mg/2ml

Solution For Injection Intraarterial Use | Intramuscular Use | Intrathecal Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 1g/10ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 5g/50ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Hospira Uk Ltd Methotrexate Hospira Uk

Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Methotrexate Medac

Methotrexate 100mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

Page 151: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 151/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Methotrexate Medac

Methotrexate 25mg/Ml Solution For Injection Intraarterial Use | Intramuscular Use | Intravenous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Methotrexate 50mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Intravenous Use | Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 10mg/0.2ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 12.5mg/0.25ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 15mg/0.3ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 17.5mg/0.35ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 20mg/0.4ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 22.5mg/0.45ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

Page 152: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 152/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 25mg/0.5ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 27.5mg/0.55ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 30mg/0.6ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)

Metoject Pen Methotrexate 7.5mg/0.15ml

Solution For Injection In Pre-Filled Pen

Subcutaneous Use

United Kingdom Mercury Pharmaceuticals Ltd. Methotrexate Mercury Pharmaceuticals

Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Morningside Healthcare Ltd Methotrexate Morningside Healthcare

Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Morningside Healthcare Ltd Methotrexate Morningside Healthcare

Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 10mg/0.4ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

Page 153: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 153/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Nordic Group B.V. Zlatal Methotrexate 12.5mg/0.5ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 15mg/0.6ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 17.5mg/0.7ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 20mg/0.8ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 22.5mg/0.9ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 25mg/Ml Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Nordic Group B.V. Zlatal Methotrexate 7.5mg/0.3ml

Solution For Injection In Pre-Filled Syringe

Intramuscular Use | Subcutaneous Use

United Kingdom Orion Corporation Methotrexate Orion Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Orion Corporation Methotrexate Orion Methotrexate 2.5mg Tablet

Tablet Oral Use

United Kingdom Pfizer Limited Maxtrex Methotrexate 10mg Tablet

Tablet Oral Use

United Kingdom Pfizer Limited Maxtrex Methotrexate 2.5mg Tablet

Tablet Oral Use

Page 154: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 154/159

Member State in EEA

Marketing authorisation holder

Invented name INN + Strength Pharmaceutical dose form

Route of Administration

United Kingdom Rosemont Pharmaceuticals Limited

Methotrexate Rosemont Pharmaceuticals

Methotrexate Disodium 2.19mg/Ml

Oral Solution Oral Use

Centrally authorised medicinal products

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/17/1172/001 Jylamvo 2 mg/ml Oral solution Oral use bottle (glass) 60 ml 1 bottle + 1 bottle adaptor + 1 dosing syringe 10 ml

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/001 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.3 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/002 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.4 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/003 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.5 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/004 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.6 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/005 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.7 ml 1 pre-filled pen + 1 swab

Page 155: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 155/159

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/006 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.8 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/007 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.9 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/008 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

1 ml 1 pre-filled pen + 1 swab

EU/1/16/1124/009 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.3 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/010 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.3 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/011 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.4 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/012 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.4 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/013 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.5 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/014 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.5 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/015 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.6 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/016 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.6 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swab (multipack)

EU/1/16/1124/017 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.7 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

Page 156: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 156/159

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/018 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.7 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/019 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.8 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/020 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.8 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/021 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.9 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/022 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

0.9 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/023 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

1 ml 4 (4 x 1) pre-filled pens + 4 (4 x 1) swabs (multipack)

EU/1/16/1124/024 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) in pre-filled pen

1 ml 6 (6 x 1) pre-filled pens + 6 (6 x 1) swabs (multipack)

EU/1/16/1124/025 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.3 ml 1 pre-filled syringe + 2 swabs

EU/1/16/1124/026 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.3 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/027 Nordimet 7.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.3 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/028 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.4 ml 1 pre-filled syringe + 2 swabs

Page 157: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 157/159

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/029 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.4 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/030 Nordimet 10 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.4 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/031 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.5 ml 1 pre-filled syringe + 2 swabs

EU/1/16/1124/032 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.5 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/033 Nordimet 12.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.5 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/034 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.6 ml 1 pre-filled syringe + 2 swabs

EU/1/16/1124/035 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.6 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/036 Nordimet 15 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.6 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/037 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.7 ml 1 pre-filled syringe + 2 swabs

Page 158: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 158/159

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/038 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.7 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/039 Nordimet 17.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.7 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/040 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.8 ml 1 pre-filled syringe + 2 swabs

EU/1/16/1124/041 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.8 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/042 Nordimet 20 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.8 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/043 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.9 ml 1 pre-filled syringe + 2 swabs

EU/1/16/1124/044 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.9 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/045 Nordimet 22.5 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

0.9 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)

EU/1/16/1124/046 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

1 ml 1 pre-filled syringe + 2 swabs

Page 159: Methotrexate - Art 31PhV - List of products Rev 1 · 30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000Facsimile

Annex I EMA/204541/2018 Page 159/159

MA (EU) number (Invented) name

Strength Pharmaceutical Form

Route of Administration

Immediate Packaging

Content (concentration)

Pack size

EU/1/16/1124/047 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

1 ml 4 (4 x 1) pre-filled syringes + 8 (4 x 2) swabs (multipack)

EU/1/16/1124/048 Nordimet 25 mg Solution for injection

Subcutaneous use

pre-filled syringe (glass) with safety device

1 ml 6 (6 x 1) pre-filled syringes + 12 (6 x 2) swabs (multipack)